| UniProt ID | TRIM3_HUMAN | |
|---|---|---|
| UniProt AC | O75382 | |
| Protein Name | Tripartite motif-containing protein 3 | |
| Gene Name | TRIM3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 744 | |
| Subcellular Localization | Cytoplasm. Early endosome . Golgi apparatus, trans-Golgi network . Cell projection, dendrite . | |
| Protein Description | Probably involved in vesicular trafficking via its association with the CART complex. [PubMed: 15772161 The CART complex is necessary for efficient transferrin receptor recycling but not for EGFR degradation] | |
| Protein Sequence | MAKREDSPGPEVQPMDKQFLVCSICLDRYQCPKVLPCLHTFCERCLQNYIPAQSLTLSCPVCRQTSILPEQGVSALQNNFFISSLMEAMQQAPDGAHDPEDPHPLSVVAGRPLSCPNHEGKTMEFYCEACETAMCGECRAGEHREHGTVLLRDVVEQHKAALQRQLEAVRGRLPQLSAAIALVGGISQQLQERKAEALAQISAAFEDLEQALQQRKQALVSDLETICGAKQKVLQSQLDTLRQGQEHIGSSCSFAEQALRLGSAPEVLLVRKHMRERLAALAAQAFPERPHENAQLELVLEVDGLRRSVLNLGALLTTSATAHETVATGEGLRQALVGQPASLTVTTKDKDGRLVRTGSAELRAEITGPDGTRLPVPVVDHKNGTYELVYTARTEGELLLSVLLYGQPVRGSPFRVRALRPGDLPPSPDDVKRRVKSPGGPGSHVRQKAVRRPSSMYSTGGKRKDNPIEDELVFRVGSRGREKGEFTNLQGVSAASSGRIVVADSNNQCIQVFSNEGQFKFRFGVRGRSPGQLQRPTGVAVDTNGDIIVADYDNRWVSIFSPEGKFKTKIGAGRLMGPKGVAVDRNGHIIVVDNKSCCVFTFQPNGKLVGRFGGRGATDRHFAGPHFVAVNNKNEIVVTDFHNHSVKVYSADGEFLFKFGSHGEGNGQFNAPTGVAVDSNGNIIVADWGNSRIQVFDSSGSFLSYINTSAEPLYGPQGLALTSDGHVVVADAGNHCFKAYRYLQ | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MAKREDSPG ------CCCCCCCCC | 21.44 | 19413330 | |
| 7 | Phosphorylation | -MAKREDSPGPEVQP -CCCCCCCCCCCCCC | 27.31 | 29255136 | |
| 23 | Phosphorylation | DKQFLVCSICLDRYQ CCCEEEEEHHHHHHC | 14.62 | 21406692 | |
| 159 | Ubiquitination | RDVVEQHKAALQRQL HHHHHHHHHHHHHHH | 34.74 | - | |
| 202 | Phosphorylation | AEALAQISAAFEDLE HHHHHHHHHHHHHHH | 11.06 | - | |
| 216 | Ubiquitination | EQALQQRKQALVSDL HHHHHHHHHHHHHHH | 35.27 | - | |
| 342 | Phosphorylation | ALVGQPASLTVTTKD HHCCCCCEEEEEEEC | 31.12 | 28857561 | |
| 344 | Phosphorylation | VGQPASLTVTTKDKD CCCCCEEEEEEECCC | 17.20 | 28857561 | |
| 346 | Phosphorylation | QPASLTVTTKDKDGR CCCEEEEEEECCCCC | 23.93 | 30177828 | |
| 347 | Phosphorylation | PASLTVTTKDKDGRL CCEEEEEEECCCCCE | 32.67 | 25690035 | |
| 357 | Phosphorylation | KDGRLVRTGSAELRA CCCCEEECCCCEEEE | 28.19 | 28348404 | |
| 359 | Phosphorylation | GRLVRTGSAELRAEI CCEEECCCCEEEEEE | 20.25 | 22964224 | |
| 412 | Phosphorylation | YGQPVRGSPFRVRAL HCCCCCCCCEEEEEC | 15.42 | 24719451 | |
| 427 | Phosphorylation | RPGDLPPSPDDVKRR CCCCCCCCHHHHHHH | 38.73 | 30266825 | |
| 437 | Phosphorylation | DVKRRVKSPGGPGSH HHHHHCCCCCCCCHH | 26.39 | 30266825 | |
| 443 | Phosphorylation | KSPGGPGSHVRQKAV CCCCCCCHHHHHHHH | 23.18 | 26055452 | |
| 454 | Phosphorylation | QKAVRRPSSMYSTGG HHHHCCCHHHCCCCC | 26.40 | 23882029 | |
| 455 | Phosphorylation | KAVRRPSSMYSTGGK HHHCCCHHHCCCCCC | 25.15 | 21712546 | |
| 457 | Phosphorylation | VRRPSSMYSTGGKRK HCCCHHHCCCCCCCC | 12.67 | 23403867 | |
| 458 | Phosphorylation | RRPSSMYSTGGKRKD CCCHHHCCCCCCCCC | 16.37 | 21712546 | |
| 459 | Phosphorylation | RPSSMYSTGGKRKDN CCHHHCCCCCCCCCC | 32.25 | 23403867 | |
| 483 | Ubiquitination | VGSRGREKGEFTNLQ ECCCCCCCCCCCCCC | 63.48 | - | |
| 487 | Phosphorylation | GREKGEFTNLQGVSA CCCCCCCCCCCCCCC | 30.62 | 22210691 | |
| 497 | Phosphorylation | QGVSAASSGRIVVAD CCCCCCCCCCEEEEC | 27.62 | 22210691 | |
| 529 | Phosphorylation | RFGVRGRSPGQLQRP EEECCCCCCCCCCCC | 35.88 | 24719451 | |
| 537 | Phosphorylation | PGQLQRPTGVAVDTN CCCCCCCCEEEECCC | 46.61 | 28102081 | |
| 579 | Ubiquitination | AGRLMGPKGVAVDRN CCCCCCCCEEEECCC | 61.36 | - | |
| 615 | Methylation | LVGRFGGRGATDRHF EEEEECCCCCCCCCC | 31.77 | 115918957 | |
| 639 | Phosphorylation | NKNEIVVTDFHNHSV CCCCEEEEECCCCEE | 23.27 | - | |
| 649 | Phosphorylation | HNHSVKVYSADGEFL CCCEEEEEECCCCEE | 7.76 | 23403867 | |
| 650 | Phosphorylation | NHSVKVYSADGEFLF CCEEEEEECCCCEEE | 23.91 | 23403867 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TRIM3_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TRIM3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TRIM3_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| TRIM3_HUMAN | TRIM3 | physical | 11331580 | |
| ACTN4_HUMAN | ACTN4 | physical | 10673389 | |
| UB2D4_HUMAN | UBE2D4 | physical | 21143188 | |
| ACTN4_HUMAN | ACTN4 | physical | 15772161 | |
| MYO5A_HUMAN | MYO5A | physical | 15772161 | |
| ODPA_HUMAN | PDHA1 | physical | 26344197 | |
| CDN1A_HUMAN | CDKN1A | physical | 24393003 | |
| UB2D1_HUMAN | UBE2D1 | physical | 24393003 | |
| UB2D2_HUMAN | UBE2D2 | physical | 24393003 | |
| UB2E1_HUMAN | UBE2E1 | physical | 24393003 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-7, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-443, AND MASSSPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-7, AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-7, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-437, AND MASSSPECTROMETRY. | |